Coma Treatment Devices Market Overview
Coma Treatment Devices Market size is estimated to reach $8.3 billion by 2027 and is poised to grow at a CAGR of 7.5% during the forecast period 2022-2027. Coma is a medical condition where the affected individual becomes unconscious and unresponsive for a prolonged period of time, and cannot be awakened by any external stimulation. Coma is a major emergency condition that is typically caused by trauma, hyperglycaemia, cardiac arrest, alcohol overdose, lack of oxygen and others. Some of the most commonly used medical devices for the treatment and diagnosis of coma include ventilators, Computerized Tomography (CT) scanners and Magnetic Resonance Imaging (MRI) systems. The rapid rise in the prevalence of hyperglycaemia among the population is a key factor driving the growth of the Coma Treatment Devices industry during the forecast period 2022-2027.
The report: “Coma Treatment Devices Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Coma Treatment Devices Market.
By Device Type: Electroencephalogram Devices, ECG Devices, CT scans,
Ventilators, MRI Scans, Monitors, IV Pumps, Blood Parameters Monitoring Devices
By Type- Toxic-Metabolic Encephalopathy and Anoxic Brain Injury.
By End User: Hospitals, and clinics.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Columbia and Rest of South America), and Rest of the World (Middle East, and Africa)
- North America dominated the coma treatment devices market in the year 2021. Presence of a highly developed healthcare infrastructure and growing consumption of alcohol in the region post the COVID-19 pandemic is contributing to the growth of the segment.
- Besides, the rapid rise in the number of COVID-19 cases across the globe has further increased the adoption of coma treatment devices in healthcare facilities as coma or persistent unresponsiveness are some of the more serious complications of the disease.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the coma treatment devices Market report.
- However, the extremely high cost of coma treatment devices and low product availability are some of the factors challenging the growth of the market during the forecast period.
Coma Treatment Devices Market Revenue Share, By Geography, 2021 (%)
For More Details on This Report - Request for Sample
Coma Treatment Devices Market Segment Analysis – By Device Type
Based on Device Type, the Coma Treatment Devices market can be segmented into Electroencephalogram Devices, ECG Devices, CT scans, Ventilators, MRI Scans, Monitors, IV Pumps, Blood Parameters Monitoring Devices and Others. The Ventilator segment accounted for the largest share of the market in 2021 and is poised to grow at a CAGR of 8.8% during the forecast period 2022-2027. Ventilators are medical devices that provide mechanical ventilation to coma patients by moving air into and out of the lungs. This helps patients breathe, even though they are in a comatose state. The Electroencephalogram Devices segment is projected to witness robust growth during the forecast period 2022-2027. EEG devices are used by medical professionals to confirm the brain death of someone in a persistent coma. Besides, they also aid doctors in determining the right amount of anaesthesia for someone in a medically induced coma.
Coma Treatment Devices Market Segment Analysis – By End User
Based on End User, the Coma Treatment Devices market can be further segmented into Hospitals and Clinics. The hospital segment accounted for the largest share of the coma treatment devices market in 2021 and is projected to grow at a CAGR of 8.1% during the forecast period 2022-2027. This can be attributed to the fact that hospitals typically have greater facilities to properly take care of coma patients, even for extended periods of time. Hospitals can provide coma patients with life support in Intensive Care Units (ICUs). Besides, most hospitals also possess diagnostic imaging systems such as CT and MRI scanners, thereby helping doctors monitor the progress of the condition throughout the treatment process. The hospital segment is also predicted to witness the fastest growth during the forecast period 2022-2027.
Coma Treatment Devices Market Segment Analysis – By Geography
Based on Geography, the Coma Treatment Devices market can be segmented into North America, Europe, Asia-Pacific, South America, and Rest of World. North America dominated the geography segment of the Coma Treatment Devices Market in 2021 with a share of approximately 37%. The rapid growth of the segment can be attributed to the presence of a highly developed healthcare sector in the region. Besides, high instances of COVID-19 cases in the US during the pandemic coupled with rapid growth in hyperglycaemia among the population are further contributing to the segment’s growth during the forecast period.
The Asia Pacific region is anticipated to register the fastest growth during the forecast period 2022-2027 owing to the growth in healthcare infrastructure development projects and the growing domestic medical device manufacturing industry in emerging economies such as China, Vietnam and India.
Coma Treatment Devices Market Drivers
Growing prevalence of hyperglycaemia is driving the market growth
The rise in the prevalence of people suffering from high blood sugar is a key factor driving the demand for coma treatment devices. According to the International Diabetes Federation (IDF), around 537 million adults between the ages of 20 and 79 suffered from diabetes in 2021. This is anticipated to rise to 643 million by 2030 and 783 million by 2045. The condition is directly responsible for approximately 6.7 million deaths each year.
Surge in COVID-19 cases is poised to increase the growth of the market
Massive surge in the number of COVID-19 cases across the globe and the emergence of new and more transmissible variants of the virus is anticipated to drive the growth of the market as coma is one of the serious complications of the disease. According to the British Broadcasting Corporation (BBC), COVID-19 affected more than 510 million people across almost 200 countries as of April 2022. The disease was also responsible for around 6.2 million deaths worldwide. According to a case report in the BMJ, approximately 3.2% of patients infected with COVID-19 require invasive ventilation. Of these, around 15% suffer from impaired consciousness.
Coma Treatment Devices Market Challenges
High cost of Coma Treatment Devices is likely to challenge the market growth
The high cost of systems necessary for the diagnosis and treatment of coma is a major factor that is challenging product adoption among end-users during the forecast period. For instance, the cost for a single, state-of-the-art, high-powered MRI machine can reach between $1 million and $3 million. Meanwhile, a single hospital grade ventilator can cost between $25,000 to $50,000. Furthermore, a single large CT scanner can cost healthcare service providers up to $2.5 million. Such a high cost of equipment is challenging for product adoption, especially in developing regions.
Coma Treatment Devices Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Coma Treatment Devices Market. In 2021, the Coma Treatment Devices Market share is fragmented by the top ten players present in the market. The Coma Treatment Devices Market, top 10 companies are:
- Johnson & Johnson
- GE Healthcare
- Siemens Healthcare
- Philips Healthcare
- Shimadzu Corporation
- Masimo Corporation
- Stryker Corp
- In April 2022, Wipro GE Healthcare announced the launch of its next-generation Revolution Aspire CT (Computed Tomography) scanner. The CT system is equipped with higher imaging intelligence to improve clinical confidence when diagnosing diseases and anomalies.
- In January 2022, OES Medical announced the launch of its new ventilator at Arab Health. The company’s Gemini-G100 is an electrically driven piston ICU ventilator with an integrated oxygen concentrator for use in intensive care.
- In December 2021, FUJIFILM Healthcare Americas Corporation unveiled the Velocity MRI System, its advanced, high-field open MRI system during the 2021 Radiological Society of North America (RSNA). The Velocity MRI system is Fujifilm’s newest MRI scanner, designed to streamline workflow and enhance the patient experience with its unique open gantry, integrated radiofrequency (RF) coils and reconstruction technologies.
Report Code: HCR 54937
Report Code: HCR 0169
Report Code: HCR 0069
For more Lifesciences and Healthcare Market reports, please click here